Blockade of CD47 increases survival of mice exposed to lethal total body irradiation

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Soto Pantoja, David R ^a   Ridnour, Lisa A ^a   Wink, David A ^a   Roberts, David D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; GTF2H1 PROTEIN, MOUSE; MORPHOLINO OLIGONUCLEOTIDE; RADIOPROTECTIVE AGENT; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR;

ACUTE RADIATION SYNDROME; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD CELL COUNT; BONE MARROW; BONE MARROW CELL; C57BL MOUSE; CELL DEATH; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; ESOPHAGUS; GENETICS; INTESTINE MUCOSA; METABOLISM; MOUSE; RADIATION DOSE; RADIATION EXPOSURE; SURVIVAL; WHOLE BODY RADIATION;

ACUTE RADIATION SYNDROME; ANIMALS; ANTIGENS, CD47; BLOOD CELL COUNT; BONE MARROW; BONE MARROW CELLS; CELL DEATH; CELL PROLIFERATION; ESOPHAGUS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MORPHOLINOS; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; SURVIVAL; THROMBOSPONDIN 1; TRANSCRIPTION FACTORS; WHOLE-BODY IRRADIATION;

MLCS; MLOWN;

EID: 84872735865     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01038     Document Type: Article

References (26)

1. Heslet, L., Bay, C. & Nepper-Christensen, S. Acute radiation syndrome (ARS)-treatment of the reduced host defense. Int J Gen Med 5, 105-115.
2. Dorr, H. &Meineke, V. Acute radiation syndrome caused by accidental radiation exposure-therapeutic principles. BMC Med 9, 126 (2011).
3. Xiao,M., Inal, C. E., Parekh, V. I., Li, X. H. &Whitnall, M. H. Role of NF-kappaB in hematopoietic niche function of osteoblasts after radiation injury. Exp Hematol 37, 52-64 (2009).
4. Singh, V. K., Ducey, E. J., Brown, D. S. & Whitnall, M. H. A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute. Int J Radiat Biol 88, 296-310 (2012).
5. Soto-Pantoja, D. R., Isenberg, J. S. & Roberts, D. D. Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation. J Genet Syndr Gene Ther 2 (2011).
6. Roberts, D. D., Miller, T. W., Rogers, N. M., Yao, M. & Isenberg, J. S. The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47. Matrix Biol 31, 162-169 (2012).
7. Frazier, E. P. et al. Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47. Matrix Biol 30, 154-161 (2011).
8. Isenberg, J. S. et al. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 281, 26069-26080 (2006). (Pubitemid 44401813)
9. Isenberg, J. S., Martin-Manso, G., Maxhimer, J. B. & Roberts, D. D. Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies. Nat Rev Cancer 9, 182-194 (2009).
10. Isenberg, J. S. et al. Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury. Am J Pathol 173, 1100-1112 (2008).
11. Isenberg, J. S. et al. Increasing survival of ischemic tissue by targeting CD47. Circ Res 100, 712-720 (2007). (Pubitemid 46594886)
12. Isenberg, J. S. et al. Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling. Surgery 144, 752-761 (2008).
13. Isenberg, J. S. et al. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg 247, 180-190 (2008).
14. Maxhimer, J. B. et al. Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling. Sci Transl Med 1, 3ra7 (2009).
15. Soto Pantoja, D. R. et al. CD47 deficiency confers cell and tissue radioprotection by activation of autophagy. Autophagy 8, 0-1 (2012).
16. Kulkarni, S., Ghosh, S. P., Hauer-Jensen, M. & Kumar, K. S. Hematological targets of radiation damage. Curr Drug Targets 11, 1375-1385 (2010).
17. Reinhold, M. I., Green, J. M., Lindberg, F. P., Ticchioni, M. & Brown, E. J. Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein/CD47 and CD28. Int Immunol 11, 707-718 (1999). (Pubitemid 29237762)
18. Bill, B. R., Petzold,A.M., Clark, K. J., Schimmenti, L. A.&Ekker, S. C.Aprimer for morpholino use in zebrafish. Zebrafish 6, 69-77 (2009).
19. Sazani, P.,Weller, D. L.&Shrewsbury, S. B. Safety pharmacology and genotoxicity evaluation of AVI-4658. Int J Toxicol 29, 143-156 (2010).
20. Iversen, P. L., Arora, V., Acker, A. J., Mason, D. H. & Devi, G. R. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans. Clin Cancer Res 9, 2510-2519 (2003). (Pubitemid 36842091)
21. Isenberg, J. S. et al. Gene silencing of CD47 and antibody ligation of thrombospondin-1 enhance ischemic tissue survival in a porcine model: implications for human disease. Ann Surg 247, 860-868 (2008). (Pubitemid 351591523)
22. Kim, D. et al. Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells. Leukemia (2012).
23. Rogers, N. M., Thomson, A. W. & Isenberg, J. S. Activation of Parenchymal CD47 Promotes Renal Ischemia-Reperfusion Injury. J Am Soc Nephrol 23, 1538-1550 (2012).
24. Jahraus, C. D. et al. Rifaximin diminishes neutropenia following potentially lethal whole-body radiation. Exp Biol Med (Maywood) 235, 900-905 (2010).
25. Rose, J., Rodrigues, G., Yaremko, B., Lock, M. & D'Souza, D. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol 91, 282-287 (2009).
26. Berkey, F. J. Managing the adverse effects of radiation therapy. Am Fam Physician 82, 381-388, 394 (2010).